摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Piperidine, 1-[(aminooxy)acetyl]- | 741246-54-8

中文名称
——
中文别名
——
英文名称
Piperidine, 1-[(aminooxy)acetyl]-
英文别名
2-aminooxy-1-piperidin-1-ylethanone
Piperidine, 1-[(aminooxy)acetyl]-化学式
CAS
741246-54-8
化学式
C7H14N2O2
mdl
——
分子量
158.2
InChiKey
KPDZFGWNUWLGOO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    Piperidine, 1-[(aminooxy)acetyl]-盐酸 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以20.2 g的产率得到1-[(氨基氧基)乙酰基]-哌啶单盐酸盐
    参考文献:
    名称:
    Synthesis of pochoxime prodrugs as potent HSP90 inhibitors
    摘要:
    Pochoximes are potent inhibitors of heat shock protein 90 (HSP90) based on the radicicol pharmacophores. Herein we present a pharmacokinetics and pharmacodynamics evaluation of this compound series as well as a phosphate prodrug strategy to facilitate formulation and improve oral bioavailability. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.04.030
  • 作为产物:
    描述:
    2-(2-Oxo-2-piperidin-1-ylethoxy)isoindole-1,3-dione 在 甲基肼 作用下, 以 甲醇 为溶剂, 生成 Piperidine, 1-[(aminooxy)acetyl]-
    参考文献:
    名称:
    Synthesis of pochoxime prodrugs as potent HSP90 inhibitors
    摘要:
    Pochoximes are potent inhibitors of heat shock protein 90 (HSP90) based on the radicicol pharmacophores. Herein we present a pharmacokinetics and pharmacodynamics evaluation of this compound series as well as a phosphate prodrug strategy to facilitate formulation and improve oral bioavailability. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.04.030
点击查看最新优质反应信息

文献信息

  • [EN] POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES<br/>[FR] DÉRIVÉS DE POCHOXIME CONVENANT POUR LE TRAITEMENT DE PATHOLOGIES EN RAPPORT AVEC HSP90
    申请人:UNIV STRASBOURG
    公开号:WO2012052843A1
    公开(公告)日:2012-04-26
    The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharamceutical composition comprising the present compound and the use of the compound as inhibitors of kinases and of the enzyme family known as heat shock protein 90 (HSP90).
    本发明包括天然产物radicicol、pochonins、pochoximes的新颖衍生物、类似物和中间体,以及它们的合成方法。本发明还提供了一种包含本化合物的药物组合物,以及将该化合物用作激酶抑制剂和热休克蛋白90(HSP90)酶家族的用途。
  • [EN] MACROCYCLIC PRODRUG COMPOUNDS USEFUL AS THERAPEUTICS<br/>[FR] COMPOSÉS DE PROMÉDICAMENTS MACROCYCLIQUES UTILISÉS COMME AGENTS THÉRAPEUTIQUES
    申请人:NEXGENIX PHARMACEUTICALS
    公开号:WO2009105755A3
    公开(公告)日:2009-11-12
  • Macrocyclic prodrug compounds useful as therapeutics
    申请人:Nexgenix Pharmaceuticals
    公开号:EP2254880B1
    公开(公告)日:2016-08-17
  • Macrocyclic Prodrug Compounds Useful as Therapeutics
    申请人:Heck James
    公开号:US20110190237A1
    公开(公告)日:2011-08-04
    The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, an inflammatory disease, a neurological or neurodegenerative disease, cancer, a cardiovascular disease, allergy, asthma, a hormone-related disease, and tumors or symptoms resulting from neurofibromatosis.
  • POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES
    申请人:Winssinger Nicolas
    公开号:US20140031302A1
    公开(公告)日:2014-01-30
    The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharmaceutical composition comprising the present compound and the use of the compound as inhibitors of kinases and of the enzyme family known as heat shock protein 90 (HSP90).
查看更多